Fri, 01st Jan 2021 12:17
NEW DELHI, Jan 1 (Reuters) - India's drug regulator on
Friday approved a coronavirus vaccine developed by AstraZeneca
and Oxford University for emergency use, two sources
with knowledge of the matter told Reuters.
A representative of India's Central Drugs Standard Control
Organization (CDSCO), whose experts were meeting for the second
time this week, declined to comment.
(Reporting by Krishna N. Das and Nigam Prusty
Editing by Gareth Jones)
(Alliance News) - AstraZeneca PLC on Wednesday said its Farxiga treatment has been approved in the US to treat some diabetes sufferers.
(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and on Friday:
(Alliance News) - AstraZeneca PLC on Monday celebrated a breakthrough therapy designation for its cancer drug Tagrisso, aimed at treating a form of no...
(Alliance News) - Stocks in London are called to open lower on Monday, setting off the week on the backfoot, with eyes on the US Federal Reserve's lat...
(Sharecast News) - Stocks in London look primed for a lower start as investors digest the gains made by far right parties in Austria, Germany, but abo...
Astrazeneca (AZN)